Summary of the Earnings Call Company Overview - The company is a premier body contouring provider, operating 32 centers across 30 states in the U.S., one in Canada, and one in the UK, having started in 2012 [3][4] - The company has performed close to 75,000 procedures, indicating significant growth and patient satisfaction [4] Core Services - The company specializes in minimally invasive body contouring services, including fat removal, fat transfer, skin tightening, and cellulite removal [5][8][10][12] - The fat removal procedure can remove up to ten pounds of fat in a single session, with patients typically returning to normal activities within 24 hours [6][44] - The average ticket size for procedures is approximately $12,000 to $13,000, with all payments made in cash [7][16] Financial Performance - In 2024, the company generated approximately $180 million in revenue and $21 million in adjusted EBITDA [19][20] - The company has a strong historical performance, with a 34% compound annual growth rate (CAGR) in top-line revenue from 2019 to 2023 [25] - The average profit per procedure is around $8,000, contributing to significant EBITDA and cash flow generation [26][28] - The company has reduced its debt from $85 million at the time of going public in 2021 to $58 million as of the end of Q2 2023 [29] Growth Strategy - The company has paused new center openings in 2025 to focus on improving same-store sales growth due to recent downturns in core business [23][24] - There are over 100 potential new center opportunities in the U.S. and around 200 when including Canada [31] - The company has successfully doubled its center footprint from 16 to 32 since 2021 [17] Market Dynamics - The company has experienced some downturns due to macroeconomic pressures affecting high-end consumers [22] - The rise of GLP-1 medications (e.g., Ozempic) is expected to impact the aesthetics market, particularly in addressing skin laxity and volume loss [48][49] - The company is piloting a skin tightening procedure to address skin laxity resulting from weight loss associated with GLP-1 usage [50] Business Priorities - The company is focusing on two main areas: enhancing company culture and improving revenue through better marketing and sales strategies [32] - Key initiatives include optimizing marketing spend, expanding financing options for patients, and introducing new services [34][35][36] - Cost-saving measures have been implemented, resulting in over $3 million in annual savings [39] Outlook - The company has reiterated its annual revenue outlook of approximately $160 million to $170 million and adjusted EBITDA of $16 million to $18 million for the year [40] - The management believes that the company has a compelling business case and anticipates strong future growth once macroeconomic conditions stabilize [53]

We're back now with cosmetic surgery chains rapidly expanding nationwide. Growing with them, the number of lawsuits over aggressive sales tactics and lacks medical standards. Aaron McLaclin has our story.Reported in partnership with KFFF Health News. >> When Aaron Schaefer lost 100 pounds, she had surgery to remove excess skin at the national cosmetic surgery chain. I remember as I got off of the operating table, um, I looked over and I saw a huge piece of skin.The first thing I thought was I was just skinn ...

Patient Safety Concerns - Sonelloo's surgical procedures led to at least one patient experiencing a life-threatening infection after skin removal surgery [1] - Patients reported experiencing excruciating pain during procedures [3] - One patient explicitly asked a surgeon to stop a procedure [2][3] Surgeon Qualifications and Training - Dr Herrera, performing liposuction and tummy tuck procedures, is a board-certified OBGYn, not a board-certified plastic surgeon [2] - Dr Herrera completed Sonobello's 6 to 8 week unaccredited training program on liposuction and tummy tucks [2] Company Response and Statistics - Sonelloo claims to prioritize patients [2] - Sonelloo states that 13 patients out of 300,000 (0.0043%) undergoing the procedure had a negative experience, which is not the norm [3] - Sonelloo uses lidocaine for pain management during procedures [1]

Patient Safety Concerns - A patient, Schaefer, experienced severe pain during a cosmetic surgery performed at Sonabello and later developed a life-threatening infection [1][2] - Schaefer is suing Sonabello, alleging negligence and lack of proper care [4] - The lawsuit is among over 200 filed against cosmetic surgery chains, raising concerns about disfiguring injuries and deaths [4][5] - At least 13 complaints were made to the Better Business Bureau, with patients reporting excruciating pain during procedures [7] Surgeon Qualifications and Training - The surgeon who performed Schaefer's surgery was a board-certified OBGYN, not a board-certified plastic surgeon, who completed Sonabello's 6 to 8 week unaccredited training program [3] - Sonabello claims its training program is rigorous and it is transparent about surgeons' qualifications [4] Company Response and Practices - Sonabello denies wrongdoing and asserts that it prioritizes patients over profits [4][5] - Sonabello uses lidocaine for pain management during surgery, keeping patients awake, claiming it is safer than general anesthesia [1] - Sonabello states that 13 negative experiences out of 300,000 patients is not the norm [8] Industry Recommendations - Experts recommend consulting with a doctor, not just a sales representative, and inquiring about the surgeon's qualifications before undergoing cosmetic procedures [10]

In the age of Ozempic, women are downsizing their breast implants and seeking surgeries that offer subtle enhancement: “We all want little perky boobs” https://t.co/0VtWZ4YY7r ...